Organizational Readiness

Provides guidance to clinicians and practices on using telehealth for substance use services during COVID-19, including benefits of using telehealth, Federal and State policy changes, private payers, and general considerations

PCSS clinical experts have created a new Performance-in-Practice (PIP) activity that will help you identify and address gaps in your practice treating patients with opioid use disorder (OUD).

This document is to assist community leaders, local and regional organizers, non-profit groups, law enforcement, public health, and members of the public in understanding and navigating effective strategies to prevent opioid overdose in their communities.

This pocket guide is intended for non-clinical drug court team members (e.g., court coordinators, judges, defense attorneys, prosecutors, parole officers, case managers, peer mentors, recovery coaches). It will describe how the team member can support both the provider and those participants prescribed or considering medication-assisted treatment (MAT).

This pocket guide is designed to help counselors and therapists working with drug court participants refer and link participants to opioid treatment services in outpatient offices, clinics, and Opioid Treatment Programs (OTPs).

This is a change guide for primary care providers on how to offer integrated care for patients with alcohol use disorder or substance use disorder; it outlines nine changes, covering both clinical and organizational implementation.

The Decision Support Tool empowers providers to estimate Medicare and Medicaid revenue across prominent integrated care services to finance these services more effectively in community mental health care, substance use treatment and primary care provider organizations. It includes a list of specific billing codes, service types, professional discipline coverage, documentation and time requirements.

Provides strategies to build support for expanding the use of medication-assisted treatment (MAT) and resources for securing buy-in.

Provides lessons learned from organizations with established MAT programs, including making the business case for MAT, securing buy-in from staff, overcoming community resistance, paying for MAT, finding prescribers, obtaining licenses and credentials, screening and assessing patients, combining medication and therapy, and sustaining a MAT program.